(Q52895013)

English

Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide.

scientific article published in June 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

phase I clinical trial

0 references

multiple sclerosis

0 references

author name string

D P Gold

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

R A Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

A B Golding

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

E E Morgan

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

T Dafashy

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

J Nelson

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

L Smith

7

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

J Diveley

8

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

J A Laxer

9

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

S P Richieri

10

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

D J Carlo

11

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

S W Brostoff

12

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

D B Wilson

13

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

Journal of Neuroimmunology

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

76

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

1-2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

29-38

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-DR, DQ and DP typing using PCR amplification and immobilized probes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of Lewis rat experimental allergic encephalomyelitis with a monoclonal antibody to the T cell receptor V beta 8.2 segment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A new synthetic route to tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin, an improved support for solid-phase peptide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune regulation in self tolerance: functional elimination of a self-reactive, counterregulatory CD8+ T lymphocyte circuit by neonatal transfer of encephalitogenic CD4+ T cells lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple Sclerosis as a Disease of Immune Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The V-region disease hypothesis: new evidence suggests it is probably wrong

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900029-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-5728(97)00029-5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/9184630

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52895013&oldid=1749509928"